These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21741354)

  • 1. Pulmonary surfactant proteins and polymer combinations reduce surfactant inhibition by serum.
    Lu KW; Pérez-Gil J; Echaide M; Taeusch HW
    Biochim Biophys Acta; 2011 Oct; 1808(10):2366-73. PubMed ID: 21741354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan with dextran added to therapeutic lung surfactants improves effectiveness in vitro and in vivo.
    Lu KW; Taeusch HW; Clements JA
    Exp Lung Res; 2013; 39(4-5):191-200. PubMed ID: 23638643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary surfactant adsorption is increased by hyaluronan or polyethylene glycol.
    Taeusch HW; Dybbro E; Lu KW
    Colloids Surf B Biointerfaces; 2008 Apr; 62(2):243-9. PubMed ID: 18065212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic lung surfactants containing SP-B and SP-C peptides plus novel phospholipase-resistant lipids or glycerophospholipids.
    Notter RH; Gupta R; Schwan AL; Wang Z; Shkoor MG; Walther FJ
    PeerJ; 2016; 4():e2635. PubMed ID: 27812430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic surfactant containing SP-B and SP-C mimics is superior to single-peptide formulations in rabbits with chemical acute lung injury.
    Walther FJ; Hernández-Juviel JM; Gordon LM; Waring AJ
    PeerJ; 2014; 2():e393. PubMed ID: 24883253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of polymers and KL(4) peptide on surface activity of pulmonary surfactant lipids.
    Lu KW; Taeusch HW
    Biochim Biophys Acta; 2010 Jun; 1798(6):1129-34. PubMed ID: 20188696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mixtures of surfactant lipids and synthetic sequences of surfactant proteins SP-B and SP-C.
    Amirkhanian JD; Bruni R; Waring AJ; Taeusch HW
    Biochim Biophys Acta; 1991 Jun; 1096(4):355-60. PubMed ID: 2065107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro.
    Cockshutt AM; Weitz J; Possmayer F
    Biochemistry; 1990 Sep; 29(36):8424-9. PubMed ID: 2252903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan decreases surfactant inactivation in vitro.
    Lu KW; Goerke J; Clements JA; Taeusch HW
    Pediatr Res; 2005 Feb; 57(2):237-41. PubMed ID: 15585679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition.
    Echaide M; Autilio C; López-Rodríguez E; Cruz A; Pérez-Gil J
    Sci Rep; 2020 Jan; 10(1):1385. PubMed ID: 31992800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A coagulative type of pulmonary surfactant depletion--a mechanism of damage to the pulmonary surfactant system].
    Koga Y
    Hokkaido Igaku Zasshi; 1994 May; 69(3):434-44. PubMed ID: 7927172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer.
    López-Rodríguez E; Ospina OL; Echaide M; Taeusch HW; Pérez-Gil J
    Biophys J; 2012 Oct; 103(7):1451-9. PubMed ID: 23062337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4.
    Manalo E; Merritt TA; Kheiter A; Amirkhanian J; Cochrane C
    Pediatr Res; 1996 Jun; 39(6):947-52. PubMed ID: 8725253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full length synthetic surfactant proteins, SP-B and SP-C, reduce surfactant inactivation by serum.
    Amirkhanian JD; Bruni R; Waring AJ; Navar C; Taeusch HW
    Biochim Biophys Acta; 1993 Jul; 1168(3):315-20. PubMed ID: 8323972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant protein interactions with neutral and acidic phospholipid films.
    Rodriguez-Capote K; Nag K; Schürch S; Possmayer F
    Am J Physiol Lung Cell Mol Physiol; 2001 Jul; 281(1):L231-42. PubMed ID: 11404266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of different hydrophobic constituents in the adsorption of pulmonary surfactant.
    Wang Z; Hall SB; Notter RH
    J Lipid Res; 1996 Apr; 37(4):790-8. PubMed ID: 8732779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pulmonary surfactant protein B (SP-B) and calcium on phospholipid adsorption and squeeze-out of phosphatidylglycerol from binary phospholipid monolayers containing dipalmitoylphosphatidylcholine.
    Yu SH; Possmayer F
    Biochim Biophys Acta; 1992 Jun; 1126(1):26-34. PubMed ID: 1606172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonionic polymers reverse inactivation of surfactant by meconium and other substances.
    William Taeusch H; Lu KW; Goerke J; Clements JA
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1391-5. PubMed ID: 10228100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins.
    Friedrich W; Schmalisch G; Stevens PA; Wauer RR
    Eur J Med Res; 2000 Jul; 5(7):277-82. PubMed ID: 10903187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of pulmonary surfactant and the treatment of acute lung injuries.
    Taeusch HW; Keough KM
    Pediatr Pathol Mol Med; 2001; 20(6):519-36. PubMed ID: 11699577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.